相关实验视频
Updated: Jul 15, 2025
08:01
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
106
血小板生长因子受体和c-KIT目标的专利景观
1Central International Intellectual Property (Baotou) Co., Ltd., Baotou, 014030, China.
Pharmaceutical patent analyst
|September 27, 2023
概括
对c-KIT和血小板衍生生生长因子受体 (PDGFR) 针对自身免疫性疾病的目标的研究揭示了不同的研发时间表. 虽然PDGFR显示出更多的生物治疗应用,但c-KIT为化学药物发现提供了优势.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 包括PDGFR在内的III型受体氨酸激酶与自身免疫性疾病有关.
- 了解PDGFR和c-KIT目标的研发 (R&D) 格局对于治疗进步至关重要.
研究的目的:
- 分析自身免疫性疾病药物开发中的PDGFR和c-KIT目标之间的研发状态和差异化.
- 为了比较治疗应用趋势和这些目标的抑制剂的化学特性.
主要方法:
- 进行了美国专利分析,以评估PDGFR和c-KIT目标的研发轨迹.
- 已识别的抑制剂的化学结构被分析为特征元素和环.
主要成果:
- c-KIT的目标研发工作早于PDGFR的目标研发工作开始.
- 目前PDGFR标在生物疗法开发中具有更广泛的应用.
- c-KIT 抑制剂经常含有硫元素或1,3-氨酸环,这表明化学药物发现的竞争优势.
- c-KIT和PDGFR都是在自身免疫性疾病中药物发现的首选目标.
结论:
- 这项研究首次在药物开发中区分了PDGFR和c-KIT的研发目标.
- 与PDGFR相比,c-KIT在化学药物发现方面具有更大的潜力.
- 这两个目标对于开发用于自身免疫疾病的新疗法仍然非常重要.
关键词:
根据PDGFR的规定.c-KIT 是一个工具.patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent专利景观 专利景观有针对性的药物药物.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:26Receptor Tyrosine Kinases
13.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K